U.S. Pharma Stock News

NasdaqGS:CG
NasdaqGS:CGCapital Markets

Carlyle Group (CG) Earnings Volatility Versus AUM Growth Narrative After FY 2025 Results

Carlyle Group (CG) just posted its FY 2025 numbers with Q4 revenue of US$1.7b and basic EPS of US$1.00, alongside trailing twelve month revenue of US$4.0b and EPS of US$2.25. Over the last few quarters, revenue has ranged from US$125.6m in Q3 2025 to US$2.4b in Q3 2024, while quarterly EPS has moved between roughly US$0.00 and US$1.67, giving investors a wide set of outcomes to assess. With net profit margin at 20.1% versus 21.5% a year earlier, this latest print puts profitability, quality,...
NasdaqGS:NTCT
NasdaqGS:NTCTCommunications

NetScout Systems (NTCT) Profitability Turnaround Challenges Cautious Narratives After FY 2026 Results

NetScout Systems (NTCT) just closed FY 2026 with fourth quarter revenue of US$203 million and basic EPS of US$0.25, supported over the trailing 12 months by total revenue of US$859 million and EPS of US$1.33. The company has seen quarterly revenue range from US$186.7 million to US$250.7 million across FY 2026, with basic EPS moving from a small loss of US$0.05 in Q1 to US$0.76 in Q3 and US$0.25 in Q4, highlighting a story centered on the shift in profitability and the durability of current...
NYSE:AMR
NYSE:AMRMetals and Mining

Alpha Metallurgical Resources (AMR) Quarterly Loss Deepens Challenging Margin Recovery Narratives

Alpha Metallurgical Resources (AMR) has just posted another tough quarter, with Q4 FY 2025 revenue of US$520.5 million and a basic EPS loss of US$1.34, compared with Q4 FY 2024 revenue of US$617.3 million and a basic EPS loss of US$0.16. Over the last six reported quarters, revenue has moved from US$671.9 million in Q3 FY 2024 to US$520.5 million in Q4 FY 2025, while basic EPS has swung from a profit of US$0.29 in Q3 FY 2024 to a loss of US$1.34 in the latest quarter. This keeps the focus...
NYSE:AMN
NYSE:AMNHealthcare

AMN Healthcare Services (AMN) TTM Loss And Margin Strain Challenge Bullish Recovery Narrative

AMN Healthcare Services (AMN) closed out FY 2025 with Q4 revenue of US$748.2 million and a basic EPS loss of US$0.20, as trailing twelve month figures show revenue of US$2.7 billion and a loss per share of US$2.48 at a share price of US$22.45. Over recent periods the company has seen quarterly revenue move from US$734.7 million in Q4 2024 to US$748.2 million in Q4 2025, while basic EPS has swung between a profit of US$0.76 in Q3 2025 and losses of up to US$3.02 earlier in the year, leaving...
NasdaqGS:SLAB
NasdaqGS:SLABSemiconductor

Has Silicon Labs (SLAB) Already Priced In Its 96% One Year Share Price Surge?

Wondering whether Silicon Laboratories at around US$217.64 is offering value or stretching expectations, especially after its strong share price performance, is a natural place to start. The stock has been relatively steady over the past week, while the 30 day return is 3.6%, year to date the share price return is 65.0% and the 1 year return sits at 95.9%. Recent coverage has focused on Silicon Laboratories in the context of the broader semiconductor sector, including how specialist chip...
NasdaqGM:UNB
NasdaqGM:UNBBanks

Union Bankshares (UNB) Non Performing Loan Surge Tests Bullish Margin Narrative

Union Bankshares (UNB) has wrapped up FY 2025 with fourth quarter revenue of US$14.0 million and basic EPS of US$0.60, contributing to trailing twelve month revenue of US$53.7 million and EPS of US$2.43. Over the last few reporting periods, revenue has ranged from US$10.6 million in Q3 2024 to US$14.2 million in Q3 2025, while quarterly EPS has moved between US$0.29 and US$0.75 across that span. This provides investors with clear data points on both top line activity and per share...
NasdaqGS:RKLB
NasdaqGS:RKLBAerospace & Defense

Rocket Lab (RKLB) Revenue Growth Tests Bullish Profitability Narratives

Rocket Lab FY 2025 results: revenue climbs while losses continue Rocket Lab (RKLB) has reported another year of rapid top line expansion, with FY 2025 Q4 revenue at US$179.7 million and a quarterly loss of US$52.9 million, equal to basic EPS of a US$0.09 loss. The company’s revenue increased from US$132.4 million in FY 2024 Q4 to US$179.7 million in FY 2025 Q4, while quarterly EPS moved from a US$0.10 loss to a US$0.09 loss over the same period. This points to strong scaling of revenue...
NasdaqGS:PTCT
NasdaqGS:PTCTBiotechs

PTC Therapeutics (PTCT) Huge Q1 Profitability Spike Tests Bullish Earnings Narratives

PTC Therapeutics (PTCT) closed FY 2025 with Q4 revenue of US$164.7 million and a basic EPS loss of US$1.67, alongside net income excluding extra items of a US$135.0 million loss, setting a mixed tone for the year. Over the past six quarters, revenue has ranged from US$196.8 million in Q3 2024 to US$1.2 billion in Q1 2025, while basic EPS has swung from an 11.09 gain in Q1 2025 to losses such as US$1.39 in Q3 2024. This gives investors a wide set of margins to weigh. With the company now...
NYSE:HLI
NYSE:HLICapital Markets

Is Record FY Profits, EPS Miss And M&A Push Altering The Investment Case For Houlihan Lokey (HLI)?

In early May 2026, Houlihan Lokey reported a year-on-year decline in quarterly earnings per share alongside record full-year profits, raised its quarterly dividend to US$0.70 per share, and highlighted an active acquisition pipeline supported by balance sheet flexibility. Despite missing analyst expectations for the quarter, the firm ended fiscal 2026 with record revenue, strong performance across all advisory segments, and plans for further accretive acquisitions to reinforce its global...
NYSE:ESE
NYSE:ESEMachinery

Earnings Growth At ESCO Technologies (ESE) Tests Margin Compression Narrative In Q1 2026

ESCO Technologies (ESE) has just opened its 2026 financial year with Q1 revenue of US$289.7 million and basic EPS of US$1.11, while trailing 12 month revenue sits at US$1.17 billion with basic EPS of US$4.83. Over the past reported periods, revenue has moved from US$214.6 million in Q1 2025 to US$289.7 million in Q1 2026, with quarterly basic EPS shifting from US$0.79 to US$1.11 over the same span as trailing earnings growth of 15.7% over the last year reflects in the current run rate. For...
NasdaqCM:PROP
NasdaqCM:PROPOil and Gas

Assessing Prairie Operating (PROP) Valuation After New US$4.2 Million Shelf Registration Filing

Prairie Operating (PROP) has filed a shelf registration to offer up to US$4.2 million in common stock, covering 4,000,000 shares. This move gives the company flexibility to raise capital. See our latest analysis for Prairie Operating. The shelf registration comes as Prairie Operating’s share price has declined 61.75% over the past 30 days and has a 47.74% year-to-date share price return. The 1-year total shareholder return is down 78.89%, pointing to fading momentum despite recent corporate...
NasdaqGS:POWI
NasdaqGS:POWISemiconductor

Power Integrations (POWI) Margin Compresses To 5% Challenging Bullish Growth Narratives

Power Integrations (POWI) has wrapped up FY 2025 with fourth quarter revenue of US$103.2 million and basic EPS of US$0.24, while trailing twelve month revenue came in at US$443.5 million with basic EPS of US$0.39. Over recent periods, the company has seen quarterly revenue move from US$105.3 million and EPS of US$0.16 in Q4 2024 to a range between US$105.5 million and US$118.9 million and EPS between a loss of US$0.02 and a profit of US$0.24 in FY 2025. This sets up a picture where investors...
NYSE:AMP
NYSE:AMPCapital Markets

Ameriprise Financial Weighs RIA Growth Legal Rulings And Solo Investor Trends

RIA team affiliated with Ameriprise Financial (NYSE:AMP) launches a newly registered investment advisor overseeing $836 million in assets. Ameriprise secures a legal win as a judge denies a forensic review of advisors' devices in an ongoing client data dispute with LPL Financial. The company releases a nationwide study on solo investors, examining their financial behaviors, concerns, and use of financial advisors. Ameriprise Financial, through its wealth management and advice driven model,...
NYSE:HRTG
NYSE:HRTGInsurance

Heritage Insurance Holdings (HRTG) Combined Ratio At 73.1% Challenges Bearish Earnings Decline Narrative

Heritage Insurance Holdings (HRTG) reported fourth quarter FY 2025 revenue of US$215.3 million with basic EPS of US$2.16, alongside trailing twelve month revenue of US$847.3 million and basic EPS of US$6.33. These figures sit against a trailing net profit margin of 23.1% versus 7.5% a year earlier and earnings growth of 217.8% over the past year. Over recent quarters, revenue has ranged from US$208.0 million to US$215.3 million, while quarterly basic EPS moved from US$0.99 in Q1 FY 2025 to...
NYSE:BMI
NYSE:BMIElectronic

Badger Meter Probes Put Utility Water Weakness And Valuation In Focus

Multiple law firms, including Kaplan Fox & Kilsheimer LLP and Bronstein, Gewirtz & Grossman, LLC, have started investigations into Badger Meter (NYSE:BMI). The reviews focus on potential securities law violations and shareholder claims following unexpectedly weak first quarter results. Sharp softness in utility water sales is at the center of investor concerns that triggered these legal inquiries. Badger Meter focuses on water metering and related technologies, an area tied to long term...
NYSE:SPG
NYSE:SPGRetail REITs

Is Simon Property Group (SPG) Attractive After Strong 1-Year Rally And DCF Upside?

If you are wondering whether Simon Property Group at around US$201.40 represents fair value or a potential bargain, this article walks through the key numbers that matter for you as a shareholder or prospective investor. The stock has recent returns of a 1.1% decline over 7 days, 5.7% over 30 days, 9.5% year to date and 29.7% over 1 year. These figures provide helpful context before weighing up what the current price might represent. Recent coverage has focused on Simon Property Group in the...
NYSE:AWR
NYSE:AWRWater Utilities

Does American States Water’s 71-Year Dividend Streak Reveal A Durable Edge In AWR’s Strategy?

American States Water Company recently reported first-quarter 2026 results, with sales and revenue of US$169.19 million and net income of US$29.95 million, while also confirming a quarterly dividend of US$0.5040 per share payable on June 2, 2026. This combination of higher quarterly earnings and the company's 360th consecutive dividend payment, extending a 71-year streak of annual dividend increases, underscores its emphasis on consistent shareholder returns. With higher first-quarter...
NYSE:GMED
NYSE:GMEDMedical Equipment

Globus Medical (GMED) Net Margin Surge To 18.3% Tests Bullish Earnings Narratives

Globus Medical (GMED) has just wrapped up FY 2025 with fourth quarter revenue of US$826.4 million and basic EPS of US$1.05, against a backdrop of trailing twelve month EPS of US$3.98 supported by net income of US$537.9 million. The company has seen revenue move from US$657.3 million in Q4 2024 to US$826.4 million in Q4 2025. Trailing net margin sits at 18.3% compared with 4.1% a year earlier, giving a clearer view of how sales and EPS are feeding through to profitability. Taken together with...
NasdaqGS:MTSI
NasdaqGS:MTSISemiconductor

A Look At MACOM Technology Solutions Holdings (MTSI) Valuation After Powerful Multi‑Period Share Price Gains

Recent performance and business overview MACOM Technology Solutions Holdings (MTSI) has attracted fresh attention after a strong run in recent periods, with the stock showing solid gains over the past month and past 3 months. The company focuses on analog semiconductor solutions used across the RF, microwave, millimeter wave, and lightwave spectrum, supplying components for wireless base stations, optical networks, radar, medical systems, satellite networks, and test and measurement...
NYSE:DVA
NYSE:DVAHealthcare

Assessing DaVita (DVA) Valuation After Its Strong Multi‑Year Share Price Performance

DaVita (DVA) has caught investor attention after a strong recent run, with the stock last closing at $196.26. That move sits against a backdrop of steady operations focused on kidney dialysis and related services. See our latest analysis for DaVita. The recent jump in DaVita’s share price, with a 7 day share price return of 26.51% and year to date share price return of 71.39%, sits alongside a 3 year total shareholder return of 105.31%. This indicates momentum that long term holders have...
NasdaqGS:CLNE
NasdaqGS:CLNEOil and Gas

Clean Energy Fuels (CLNE) Quarterly Loss Deepens To US$43 Million Challenging Bullish Narratives

Clean Energy Fuels (CLNE) has closed out FY 2025 with fourth quarter revenue of US$112.3 million and a basic EPS loss of US$0.20, alongside a trailing twelve month revenue base of US$424.8 million and a loss of US$1.01 per share. Over recent quarters, the company has seen revenue move from US$103.8 million in Q1 2025 to US$112.3 million in Q4 2025, while quarterly basic EPS losses have ranged from US$0.60 in Q1 2025 to US$0.20 in Q4 2025, keeping margins in negative territory and highlighting...
NYSE:DNA
NYSE:DNALife Sciences

Ginkgo Bioworks Holdings (DNA) TTM Net Loss Of US$312.8 Million Reinforces Bearish Narratives

Ginkgo Bioworks Holdings (DNA) has wrapped up FY 2025 with fourth quarter revenue of about US$33.4 million and a basic EPS loss of US$1.41, alongside a net income loss of US$80.8 million. The company has seen trailing twelve month revenue move from US$227.0 million in Q4 2024 to US$170.2 million in Q4 2025. Over the same period, trailing EPS has shifted from a loss of US$10.54 to a loss of US$5.64, indicating that the business is still absorbing heavy costs even as losses on a per share basis...
NasdaqGS:LILA
NasdaqGS:LILATelecom

Liberty Latin America (LILA) Heavy FY 2025 Loss Challenges Bullish Turnaround Narratives

Liberty Latin America (LILA) has just wrapped up FY 2025 with Q4 revenue of US$1,159.5 million and a basic EPS loss of US$0.27, while trailing twelve month revenue came in at US$4.4 billion with a basic EPS loss of US$3.06. Over recent quarters, revenue has ranged from US$1,083.5 million in Q1 2025 to US$1,159.5 million in Q4 2025, as EPS has moved between a loss of US$2.12 in Q2 2025 and a small profit of US$0.02 in Q3 2025, highlighting that earnings remain volatile even on a multi quarter...
NasdaqGS:ICFI
NasdaqGS:ICFIProfessional Services

ICF International (ICFI) Margin Compression To 4.9% Tests Bullish Growth Narratives

ICF International (ICFI) closed FY 2025 with fourth quarter revenue of US$443.7 million and basic EPS of US$0.94, while trailing 12 month revenue was US$1.9 billion and EPS reached US$4.97. Over the last six reported quarters, the company has seen quarterly revenue move from US$517.0 million in Q3 2024 to US$443.7 million in Q4 2025, with basic EPS ranging from US$1.74 in Q3 2024 to US$0.94 most recently. With trailing net profit margins in the mid single digits and earnings forecasts...